利德曼上涨5.47%，报11.18元/股

Core Viewpoint - Lidman Biochemical Co., Ltd. has shown a significant stock price increase and is actively engaged in the development and production of biochemical reagents, aiming to enhance the quality of life and advance biological sciences [1][2]. Group 1: Stock Performance - On August 12, Lidman’s stock rose by 5.47%, reaching a price of 11.18 yuan per share, with a trading volume of 2.11 billion yuan and a turnover rate of 3.59%, resulting in a total market capitalization of 60.82 billion yuan [1]. Group 2: Company Overview - Lidman is located in Beijing Economic and Technological Development Zone and operates 10 subsidiaries along with a nationwide distribution network, achieving a daily production capacity of 4000 liters [1]. - The company is committed to promoting advancements in biological sciences and improving the quality of life for people, having established a business organization across the country to better understand market trends and meet customer needs [1]. Group 3: Financial Performance - As of July 31, Lidman had 17,000 shareholders, with an average of 31,900 circulating shares per person [2]. - For the first quarter of 2025, Lidman reported operating revenue of 78.91 million yuan, a year-on-year decrease of 16.61%, while the net profit attributable to shareholders was -1.25 million yuan, reflecting a year-on-year increase of 53.73% [2].